The term “precision medicine” has become more prominent because of the advances in healthcare and technology that are enabling a greater understanding of the predisposition to certain diseases and/or ways to prevent them. These advances have allowed for the development of therapies that are directed toward specific patients with more specific disease profiles.
The team at Persei vivarium would like to wish you a Merry Christmas and a healthy 2021.
This year, more than ever, we hope you can enjoy the holidays safely, and that the coming year arrives full of health and new and prosperous beginnings.
Our best wishes for you and for your families and friends.
EPICOS, the clinical trial for prevention of COVID-19 in healthcare workers, developed with Persei vivarium technology, is expanding to Latin America
EPICOS, the clinical trial for prevention of coronavirus infection in healthcare workers, promoted by the Spanish Ministry of Health and managed by the technology and teams at Persei vivarium and Effice Research, has been expanded to Latin America, where they intend to enroll 2,080 more professionals.
Patient Reported Outcomes (PROs) and Patient Reported Outcome Measures (PROMs): What are they and what do they provide?
As we have recently mentioned in articles like “Technology and the patient are keys to the future of clinical studies,” there is a growing tendency to complement the clinical information collected about diseases and treatments with the information provided directly by patients during the course of their disease.
As we do every year, this Thursday, October 29th, we are celebrating World Stroke Day, with the goal of providing more visibility for this disease. In Spain, more than 187 persons out of every 100,000 are affected every year, according to data from the Spanish Society of Neurology (SEN).